DOJ-OGR-00015762.json 1.8 KB

12345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455
  1. {
  2. "document_metadata": {
  3. "page_number": "33",
  4. "document_number": "DOJ-OGR-00015762",
  5. "date": "2/14/2005",
  6. "document_type": "Pharmaceuticals list",
  7. "has_handwriting": false,
  8. "has_stamps": false
  9. },
  10. "full_text": "Pharmaceuticals\n2 bottles Bayer aspirin\nTylenol\n2 Aleve\n2 Robitussin cough medicine\nNyquil\nRobitussin cough sweets\nHalls cough sweets\nBandages\nAntiseptic for cuts\nNeosporin\nEchinacea\nZinc lozengers\nVitamin C\nVitamin B\nVitamin E\nFolic Acid\nMulti vitamin twin tab 1 a day\nCalcium twin tab\nDATE: 2/14/2005\nSIGNATURE:\nDOJ-OGR-00015762",
  11. "text_blocks": [
  12. {
  13. "type": "printed",
  14. "content": "Pharmaceuticals",
  15. "position": "top"
  16. },
  17. {
  18. "type": "printed",
  19. "content": "2 bottles Bayer aspirin\nTylenol\n2 Aleve\n2 Robitussin cough medicine\nNyquil\nRobitussin cough sweets\nHalls cough sweets\nBandages\nAntiseptic for cuts",
  20. "position": "left"
  21. },
  22. {
  23. "type": "printed",
  24. "content": "Neosporin\nEchinacea\nZinc lozengers\nVitamin C\nVitamin B\nVitamin E\nFolic Acid\nMulti vitamin twin tab 1 a day\nCalcium twin tab",
  25. "position": "right"
  26. },
  27. {
  28. "type": "printed",
  29. "content": "DATE: 2/14/2005",
  30. "position": "bottom left"
  31. },
  32. {
  33. "type": "printed",
  34. "content": "SIGNATURE:",
  35. "position": "bottom middle"
  36. },
  37. {
  38. "type": "printed",
  39. "content": "DOJ-OGR-00015762",
  40. "position": "bottom right"
  41. }
  42. ],
  43. "entities": {
  44. "people": [],
  45. "organizations": [],
  46. "locations": [],
  47. "dates": [
  48. "2/14/2005"
  49. ],
  50. "reference_numbers": [
  51. "DOJ-OGR-00015762"
  52. ]
  53. },
  54. "additional_notes": "The document appears to be a list of pharmaceuticals with a date and signature field at the bottom. The document is likely related to a medical or pharmaceutical context."
  55. }